Belite Bio (BLTE) Tops Q4 EPS by 15c

Belite Bio (NASDAQ: BLTE) reported Q4 EPS of ($0.38), $0.15 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Belite Bio (BLTE) click here.

You May Also Be Interested In

• Belite Bio, Inc, ADR (BLTE) PT Raised to $214 at H.C. Wainwright
• The Honest Co. (HNST) PT Raised to $5.70 at Morgan Stanley, 'Diaper Pressure Continues'
• Cencora says Walgreens volumes shift, reaffirms guidance, shares sink